Skip to search formSkip to main contentSkip to account menu

hemantane

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Activities of noncompetitive NMDA receptor antagonists (aminoadamantane derivatives) were assessed in random-bred rats with… 
2018
2018
Hemantane is an antiparkinsonian drug with pronounced analgesic and anti-inflammatory properties. The present work evaluated… 
2017
2017
Activity of hemantane, an amino adamantane derivative, exhibiting the properties of lowaffinity non-competitive NMDA receptor… 
2016
2016
The efficacy of some aminoadamantane derivatives used as neurodegeneration treatments is due to their ability to block NMDA… 
2016
2016
s | 67 symptoms gradually decreased. Subsequently, we resumed HBO. Combination therapy of TRH and HBO dramatically improved to… 
2015
2015
Hemantane demonstrated a pronounced antiparkinsonian activity in the model of hemiparkinsonian syndrome provoked in rats by… 
2014
2014
Hemantane is a novel antiparkinsonian drug that is undergoing clinical trials. Hemantane in the dosage range 10 – 40 mg/kg… 
2013
2013
A large body of literature supports the idea that inflammation exacerbates neurodegenerative pathology. This idea is also… 
2011
2011
Chronic administration of levodopa and benserazide (10 and 15 mg/kg, respectively) cause the development of dyskinesia in rats… 
2004
2004
N-(Adamant-2-yl)hexamethyleneimine hydrochloride (hemantane) is a new potential antiparkinsonian drug with a complex mechanism of…